Euro Tech Holdings Company Limited (NASDAQ: CLWT) — FY2021 Form 20-F
Reporting period: Fiscal year ended December 31, 2021. This is an annual report, not a standalone fourth-quarter report; the filing text does not provide separate Q4 results. Financial statements are prepared under U.S. GAAP and reported in U.S. dollars. Unless stated otherwise, amounts below are US$ millions.
Business context and results
Euro Tech distributes water-treatment, laboratory and process-control products and provides water and wastewater engineering services, primarily in Hong Kong and mainland China. It reports two segments: trading and manufacturing, and engineering. Revenue grew substantially as engineering projects were completed and ballast-water-treatment-system (BWTS) sales increased.
| Metric | FY2021 | FY2020 |
|---|---|---|
| Revenue | $21.388 | $13.357 |
| Gross profit / margin | $5.695 / 26.6% | $3.685 / 27.6% |
| Operating income (loss) | $0.781 | ($1.701) |
| Net income (loss), consolidated | $1.366 | $0.402 |
| Net income attributable to Euro Tech shareholders | $0.989 | $0.769 |
| Operating cash flow | $2.201 | ($2.035) |
Revenue increased 60.1% year over year. Engineering revenue rose to $11.769 million from $3.881 million; trading and manufacturing revenue increased modestly to $9.619 million from $9.476 million. Engineering segment operating income was $0.846 million, versus a $1.027 million loss; trading and manufacturing reported $0.140 million income, versus a $0.488 million loss. Selling and administrative expenses declined 8.6% to $4.911 million. FY2021 included $0.355 million of equity-method income from the 19.4%-owned affiliate Blue Sky, down from $0.435 million.
Cash, debt and liquidity
- Cash and cash equivalents were $5.269 million at year-end, up from $3.519 million; an additional $1.411 million was restricted cash (2020: $1.672 million).
- Working capital was $5.099 million, compared with $4.915 million in FY2020. Current assets were $11.504 million and current liabilities $6.405 million.
- Operating cash flow was $2.201 million; investing activities provided $0.358 million and financing activities used $1.016 million, including the $1.031 million dividend payment. Cash, cash equivalents and restricted cash together increased $1.489 million, including exchange-rate effects.
- Bank borrowings were $0.376 million, versus $0.361 million. Available banking facilities were approximately $0.897 million and secured by a matching bank deposit; the company reported covenant compliance. Lease obligations totaled $0.216 million.
- Accounts receivable, net, rose to $3.631 million from $3.199 million; $2.190 million was past due, including $17,000 at least 91 days overdue. The allowance for doubtful accounts was $30,000.
Material changes and unusual items
- Revenue increased from FY2020’s pandemic-affected level, principally reflecting higher Pact-Yixing engineering revenue, project completions and BWTS sales. The company reported selling four port BWTS sets and eight vessel BWTS sets during FY2021.
- Gross margin eased by 1.0 percentage point to 26.6%, despite gross profit increasing 54.5%.
- FY2020 included a $1.429 million gain on disposal of property; FY2021 recorded a $10,000 loss on property and equipment disposal. FY2020 also included $147,000 of Hong Kong salary subsidies. These items affect year-over-year comparisons.
- The company paid a special cash dividend of approximately $1.031 million in 2021. Management said it did not presently intend to declare cash dividends in the foreseeable future.
- Backlog for the engineering segment was $5.400 million at year-end, down from $11.581 million. Management cautions that backlog may be canceled or changed and may not predict future results.
Outlook, risks and contingencies
Management plans to continue promoting BWTS and port-treatment systems, streamline costs and pursue engineering and product-development opportunities. It anticipated spending up to an additional $120,000 on BWTS-related research and development in FY2022. The filing provides no revenue or earnings guidance and gives no assurance that cost reductions or product initiatives will achieve sustained profitability.
- COVID-19 had materially disrupted 2020 operations; the company reported no significant disruption in 2021, but warned that renewed outbreaks, restrictions, supply interruptions and delayed projects could affect future results. Management expected a continuing adverse effect on overseas business, with the domestic impact uncertain.
- Revenue and operations are concentrated in China and Hong Kong. PRC policy, legal and regulatory changes—including uncertainty around overseas-listing filings and cybersecurity/data rules—could affect operations or listing status. The company reported no CSRC or CAC inquiry or objection as of the report date.
- The company disclosed that its Hong Kong-based auditor was in a jurisdiction where the PCAOB had determined it could not conduct complete inspections. The filing discusses potential delisting risk under the Holding Foreign Companies Accountable Act.
- Currency exposure is not adequately hedged. The company cited RMB, HKD, U.S. dollar, yen and euro exposures, as well as PRC restrictions on currency conversion and remittances.
- Supplier and customer concentration remain relevant: the largest supplier accounted for 42% of purchases in 2021; the three largest customers represented about 20% of revenue, with one customer at 15%. Key supplier arrangements include short-term or authorization-letter arrangements.
- The company reported no material unresolved litigation or contingencies at year-end. It disclosed a put option held by non-controlling owners of Pact-Yixing with no stated expiry date; the potential purchase price is based on a formula tied to prior-year earnings.
Most important facts for investors to verify
- Whether FY2021’s engineering revenue growth and $5.4 million ending backlog translate into repeatable revenue, margins and operating cash flow.
- Receivable collection, especially the $2.190 million past-due balance, and the adequacy of the $30,000 allowance.
- Availability of cash for the holding company, including restrictions on $1.411 million of cash and PRC limits on dividend remittances; no dividends were distributed from PRC subsidiaries to Far East in 2019–2021.
- Exposure to supplier concentration, the 42% share of purchases from the largest supplier, major-customer dependence and the Pact-Yixing put option.
- Developments in PCAOB inspection access, HFCAA requirements, PRC overseas-listing rules and other regulatory requirements relevant to Nasdaq listing.
- Confirmation of the post-year-end share changes: the filing reports a January 2022 bonus issue of one share for every two held and 7,732,132 shares outstanding as of the cover-page reporting date.